Home › Funds › Marshall Wace › BCLI
Marshall Wace position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q2 2023)67.42K sh
Reported value held$138.88K
Portfolio Weight0.00%
First reportedQ3 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 13.02K | $58.00K | New |
| Q4 2022 | 37.58K | $61.63K | Add |
| Q2 2023 | 67.42K | $138.88K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.